Pavlov Chavdar S, Casazza Giovanni, Semenistaia Marianna, Nikolova Dimitrinka, Tsochatzis Emmanuel, Liusina Ekaterina, Ivashkin Vladimir T, Gluud Christian
The Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen, Denmark, DK-2100.
Cochrane Database Syst Rev. 2016 Mar 2;3(3):CD011602. doi: 10.1002/14651858.CD011602.pub2.
Heavy alcohol consumption causes alcoholic liver disease and is a causal factor of many types of liver injuries and concomitant diseases. It is a true systemic disease that may damage the digestive tract, the nervous system, the heart and vascular system, the bone and skeletal muscle system, and the endocrine and immune system, and can lead to cancer. Liver damage in turn, can present as multiple alcoholic liver diseases, including fatty liver, steatohepatitis, fibrosis, alcoholic cirrhosis, and hepatocellular carcinoma, with presence or absence of hepatitis B or C virus infection. There are three scarring types (fibrosis) that are most commonly found in alcoholic liver disease: centrilobular scarring, pericellular fibrosis, and periportal fibrosis. When liver fibrosis progresses, alcoholic cirrhosis occurs. Hepatocellular carcinoma occurs in 5% to 15% of people with alcoholic cirrhosis, but people in whom hepatocellular carcinoma has developed are often co-infected with hepatitis B or C virus.Abstinence from alcohol may help people with alcoholic disease in improving their prognosis of survival at any stage of their disease; however, the more advanced the stage, the higher the risk of complications, co-morbidities, and mortality, and lesser the effect of abstinence. Being abstinent one month after diagnosis of early cirrhosis will improve the chance of a seven-year life expectancy by 1.6 times. Liver transplantation is the only radical method that may change the prognosis of a person with alcoholic liver disease; however, besides the difficulties of finding a suitable liver transplant organ, there are many other factors that may influence a person's survival.Ultrasound is an inexpensive method that has been used for years in clinical practice to diagnose alcoholic cirrhosis. Ultrasound parameters for assessing cirrhosis in people with alcoholic liver disease encompass among others liver size, bluntness of the liver edge, coarseness of the liver parenchyma, nodularity of the liver surface, size of the lymph nodes around the hepatic artery, irregularity and narrowness of the inferior vena cava, portal vein velocity, and spleen size.Diagnosis of cirrhosis by ultrasound, especially in people who are asymptomatic, may have its advantages for the prognosis, motivation, and treatment of these people to decrease their alcohol consumption or become abstinent.Timely diagnosis of alcoholic cirrhosis in people with alcoholic liver disease is the cornerstone for evaluation of prognosis or choosing treatment strategies.
To determine the diagnostic accuracy of ultrasonography for detecting the presence or absence of cirrhosis in people with alcoholic liver disease compared with liver biopsy as reference standard.To determine the diagnostic accuracy of any of the ultrasonography tests, B-mode or echo-colour Doppler ultrasonography, used singly or combined, or plus ultrasonography signs, or a combination of these, for detecting hepatic cirrhosis in people with alcoholic liver disease compared with liver biopsy as a reference standard, irrespective of sequence.
We performed searches in The Cochrane Hepato-Biliary Group Controlled Trials Register, The Cochrane Hepato-Biliary Group Diagnostic Test Accuracy Studies Register, The Cochrane Library (Wiley), MEDLINE (OvidSP), EMBASE (OvidSP), and the Science Citation Index Expanded to 8 January 2015. We applied no language limitations.We screened study references of the retrieved studies to identify other potentially relevant studies for inclusion in the review and read abstract and poster publications.
Three review authors independently identified studies for possible inclusion in the review. We excluded references not fulfilling the inclusion criteria of the review protocol. We sent e-mails to study authors.The included studies had to evaluate ultrasound in the diagnosis of hepatic cirrhosis using only liver biopsy as the reference standard.The maximum time interval of investigation with liver biopsy and ultrasonography should not have exceeded six months. In addition, ultrasonography could have been performed before or after liver biopsy.
We followed the Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy.
The review included two studies that provided numerical data regarding alcoholic cirrhosis in 205 men and women with alcoholic liver disease. Although there were no applicability concerns in terms of participant selection, index text, and reference standard, we judged the two studies at high risk of bias. Participants in both studies had undergone both liver biopsy and ultrasonography investigations. The studies shared only a few comparable clinical signs and symptoms (index tests).We decided to not perform a meta-analysis due to the high risk of bias and the high degree of heterogeneity of the included studies.
AUTHORS' CONCLUSIONS: As the accuracy of ultrasonography in the two included studies was not informative enough, we could not recommend the use of ultrasonography as a diagnostic tool for liver cirrhosis in people with alcoholic liver disease. In order to be able to answer the review questions, we need diagnostic ultrasonography prospective studies of adequate sample size, enrolling only participants with alcoholic liver disease.The design and report of the studies should follow the Standards for Reporting of Diagnostic Accuracy. The sonographic features, with validated cut-offs, which may help identify clinical signs used for diagnosis of fibrosis in alcoholic liver disease, should be carefully selected to achieve maximum diagnostic accuracy on ultrasonography.
大量饮酒会导致酒精性肝病,是多种肝损伤及伴随疾病的病因。它是一种真正的全身性疾病,可能损害消化道、神经系统、心脏和血管系统、骨骼和骨骼肌系统以及内分泌和免疫系统,并可导致癌症。肝脏损伤反过来又可表现为多种酒精性肝病,包括脂肪肝、脂肪性肝炎、纤维化、酒精性肝硬化和肝细胞癌,无论是否存在乙型或丙型肝炎病毒感染。酒精性肝病中最常见的三种瘢痕形成类型(纤维化)为:小叶中央瘢痕形成、细胞周围纤维化和汇管区周围纤维化。当肝纤维化进展时,会发生酒精性肝硬化。酒精性肝硬化患者中5%至15%会发生肝细胞癌,但发生肝细胞癌的患者常合并感染乙型或丙型肝炎病毒。戒酒可能有助于酒精性疾病患者在疾病的任何阶段改善生存预后;然而,疾病阶段越晚,并发症、合并症和死亡率的风险越高,戒酒的效果越小。早期肝硬化诊断后戒酒一个月可使七年预期寿命的机会提高1.6倍。肝移植是唯一可能改变酒精性肝病患者预后的根治方法;然而,除了寻找合适的肝移植器官困难外,还有许多其他因素可能影响患者的生存。超声是一种廉价的方法,多年来一直用于临床实践中诊断酒精性肝硬化。评估酒精性肝病患者肝硬化的超声参数包括肝脏大小、肝边缘钝圆、肝实质粗糙、肝表面结节状、肝动脉周围淋巴结大小、下腔静脉不规则和狭窄、门静脉流速以及脾脏大小。通过超声诊断肝硬化,尤其是对无症状患者,可能对其预后评估、促使其减少饮酒或戒酒以及治疗具有优势。及时诊断酒精性肝病患者的酒精性肝硬化是评估预后或选择治疗策略的基石。
以肝活检作为参考标准,确定超声检查在检测酒精性肝病患者是否存在肝硬化方面的诊断准确性。以肝活检作为参考标准,确定单独使用或联合使用B型或彩色多普勒超声检查、或加上超声征象、或这些的组合,在检测酒精性肝病患者肝硬化方面的诊断准确性,不考虑顺序。
我们在Cochrane肝胆组对照试验注册库、Cochrane肝胆组诊断试验准确性研究注册库、Cochrane图书馆(Wiley)、MEDLINE(OvidSP)、EMBASE(OvidSP)和科学引文索引扩展版中进行检索,检索截至2015年1月8日。我们未设语言限制。我们筛选检索到的研究的参考文献,以识别其他可能相关的研究纳入综述,并阅读摘要和海报出版物。
三位综述作者独立识别可能纳入综述的研究。我们排除不符合综述方案纳入标准的参考文献。我们给研究作者发送电子邮件。纳入的研究必须仅以肝活检作为参考标准评估超声在肝硬化诊断中的应用。肝活检和超声检查调查的最大时间间隔不应超过六个月。此外,超声检查可在肝活检之前或之后进行。
我们遵循Cochrane诊断试验准确性系统评价手册。
该综述纳入两项研究,提供了205例酒精性肝病男性和女性中关于酒精性肝硬化的数值数据。尽管在参与者选择、索引文本和参考标准方面不存在适用性问题,但我们判断这两项研究存在高偏倚风险。两项研究的参与者均接受了肝活检和超声检查。两项研究仅共享少数可比的临床体征和症状(索引试验)。由于纳入研究存在高偏倚风险和高度异质性,我们决定不进行Meta分析。
由于纳入的两项研究中超声检查的准确性信息不足,我们无法推荐将超声检查作为酒精性肝病患者肝硬化的诊断工具。为了能够回答综述问题,我们需要有足够样本量的诊断性超声前瞻性研究,仅纳入酒精性肝病患者。研究的设计和报告应遵循诊断准确性报告标准。应仔细选择具有验证截断值的超声特征,这些特征可能有助于识别用于诊断酒精性肝病纤维化的临床体征,以在超声检查中实现最大诊断准确性。